US 9725496
Immunoglobulin chimeric monomer-dimer hybrids
granted A61KA61K38/00A61K47/60
Quick answer
US patent 9725496 (Immunoglobulin chimeric monomer-dimer hybrids) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/642, A61K47/68